23 December 2020>: Clinical Research
Safety and Efficacy of Therapeutic Erythrocytapheresis Treatment in Chronic Mountain Sickness Patients in Shigatse, Tibet, China
Mingyuan Niu 1BCD* , Shekhar Singh 2EF* , Ma Mi 1B , Pian Bian 1B , Yawei Xu 2D , Zhuoga Deji 1AB* , Duoji Mima 1A* , Xiankai Li 2ACEG*DOI: 10.12659/MSM.927853
Med Sci Monit 2020; 26:e927853
Table 1 Baseline characteristics of the participants.
n | % | |
---|---|---|
Age (yrs) | 44±7 | |
Gender | ||
Male | 31 | 96.7 |
Female | 1 | 3.3 |
BMI (kg/m) | 25.32±3.60 | |
History of hypertension | 15 | 46.9 |
History of DM | 1 | 3.1 |
History of dyslipidemia | 9 | 28.1 |
History of smoking | 25 | 78.1 |
Smoking (cigarettes/day) | 20±15 | |
History of TIA | 1 | 3.1 |
History of stroke | 2 | 6.3 |
History of CHD | 0 | |
History of angina | 0 | |
History of COPD | 3 | 9.4 |
History of hyperuricemia | 25 | 78.1 |
History of CKD | 0 | |
BMI – body mass index; DM – diabetes mellitus; TIA – transient ischemic attack; COPD – chronic obstructive pulmonary disease; CKD – chronic kidney disease. |